IPP Bureau
Imfinzi plus chemotherapy approved in China as for metastatic biliary tract cancer
By IPP Bureau - November 16, 2023
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
Sanofi completes closing for potential first-in-class vaccine against ExPEC
By IPP Bureau - November 16, 2023
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
JB Pharma Q2 FY24 PAT up 36% to Rs. 151 Cr
By IPP Bureau - November 15, 2023
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
IOL Chemicals and Pharmaceuticals Q2 PAT jumps 141% to Rs. 37.8 Cr
By IPP Bureau - November 15, 2023
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Kesin Pharma announces FDA approval and availability of Likmez oral suspension
By IPP Bureau - November 15, 2023
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Teva, Royalty Pharma collaborate to further accelerate Olanzapine LAI program
By IPP Bureau - November 15, 2023
Phase 3 data expected in the second half of 2024
Wockhardt Q2 FY24 consolidated loss lowers at Rs. 77 Cr
By IPP Bureau - November 15, 2023
Wockhardt has reported total income of Rs. 777 crores during the period ended September 30, 2023
Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr
By IPP Bureau - November 15, 2023
Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023
Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr
By IPP Bureau - November 15, 2023
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
Biocon Biologics receives MHRA, UK Approval for Biosimilar Aflibercept ‘Yesafili’
By IPP Bureau - November 14, 2023
Yesafili, received marketing authorization approval from the European Commission for the European Union
AstraZeneca to leverage its capabilities to boost US renewable natural gas productivity
By IPP Bureau - November 14, 2023
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
BioPhy launches AI platform to accelerate the drug development market
By IPP Bureau - November 14, 2023
The company has raised US$4.5 million in funding for its AI operating system
Bayer and Recursion focus research collaboration on Oncology
By IPP Bureau - November 14, 2023
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr
By IPP Bureau - November 14, 2023
Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023
Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
By IPP Bureau - November 13, 2023
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
